References
1 Micieli R, & Alavi A. (2018). Eruptive lentiginosis in resolving psoriatic plaques. JAAD Case Reports, 4(9), 924–929. doi:10.1016/j.jdcr.2018.07.021
2 Friedland R, David M, Feinmesser M, Barzilai A, & Hodak E. (2011). NB-UVB (311-312 nm)-induced lentigines in patients with mycosis fungoides: a new adverse effect of phototherapy. Journal of the European Academy of Dermatology and Venereology, 26(9), 1158–1162. doi:10.1111/j.1468-3083.2011.04189.x
3 Bovenschen HJ, Tjioe M, Vermaat H, Hoop D, Witteman BMJ., Janssens RWA., … Kerkhof PCM. (2006). Induction of eruptive benign melanocytic naevi by immune suppressive agents, including biologicals. British Journal of Dermatology, 154(5), 880–884. doi:10.1111/j.1365-2133.2006.07189.x
4 Villalón G, Martín JM, Pinazo MI, Calduch L, Alonso V, Jordá E. (2009). Focal Acral Hyperpigmentation in a Patient Undergoing Chemotherapy with Capecitabine. American Journal of Clinical Dermatology, 10(4), 261–263.  doi:10.2165/00128071-200910040-00006
5 Wolf R, Orion E, & Davidovici B. (2008). Acral lentigines: a new paraneoplastic syndrome. International Journal of Dermatology, 47(2), 168–170. doi:10.1111/j.1365-4632.2008.03223.x
6 Woodhouse J, Maytin EV. (2005). Eruptive nevi of the palms and soles.Journal of the American Academy of Dermatology, 52(5), S96–S100.  doi:10.1016/j.jaad.2004.08.009
7 Martín Hernández, JM, Donat Colomer J, Monteagudo Castro C, Fernández-Delgado Cerdá R, Alonso Usero V, Jordá Cuevas E. (2006). Nevos acrales eruptivos tras quimioterapia en niños afectados de leucemia linfoblástica aguda. Anales de Pediatría, 65(3), 260–262.  doi:10.1157/13092164
8 Park YJ, Soh BW, Lee ES. Acral lentiginosis associated with tegafur/gimeracil/oteracil (TS-1). Eur J Dermatol . 2017;27(2):209-210. doi:10.1684/ejd.2016.2953
9 Reutter JC, Long EM, Morrell DS, Thomas NE, Groben PA. (2007). Eruptive Post-Chemotherapy In Situ Melanomas and Dysplastic Nevi. Pediatric Dermatology, 24(2), 135–137.  doi:10.1111/j.1525-1470.2007.00359.x